| An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® (NCT01664039) | Alcon Research | 2012-09-01 |
| Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma (NCT01693315) | Amakem, NV | 2012-09-01 |
| Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients (NCT01682460) | University of Waterloo | 2012-08-01 |
| Randomized Controlled Trial on Visual Field Training (NCT01669031) | Oftalmologia Hospital Sotero del Rio | 2012-08-01 |
| Stem Cell Ophthalmology Treatment Study (NCT01920867) | MD Stem Cells | 2012-08-01 |
| Glaucoma Biomarkers (NCT01677507) | University of Michigan | 2012-08-01 |
| Building a Database of Results From People Without Eye Problems (NCT02627339) | Wills Eye | 2012-08-01 |
| AqueSys Microfistula Implant in Refractory Glaucoma (NCT01640756) | AqueSys, Inc. | 2012-07-01 |
| Optical Coherence Tomography (OCT) Data Collection Study (NCT01641835) | Heidelberg Engineering GmbH | 2012-07-01 |
| Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies (NCT02199158) | Instituto de Oftalmología Fundación Conde de Valenciana | 2012-07-01 |
| The Laser in Pseudoexfoliation (LIP) Study (NCT01704989) | Nova Scotia Health Authority | 2012-06-01 |
| Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy (NCT01514721) | Alcon Research | 2012-06-01 |
| Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI (NCT01621841) | University Hospital, Bordeaux | 2012-06-01 |
| Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU) (NCT01592955) | EyeTechCare | 2012-05-01 |
| Switching From Preserved to Preserved-free Treatments for Glaucoma. (NCT01433900) | Paolo Fogagnolo | 2012-05-01 |
| Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye (NCT01348672) | University of Toronto | 2012-03-01 |
| Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil (NCT01514734) | Alcon Research | 2012-03-01 |
| Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves (NCT01535768) | Credit Valley EyeCare | 2012-02-01 |
| Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves (NCT01883856) | Peter Netland, MD | 2012-02-01 |
| The Impact of Ocular Diseases on Driving: a Prospective Study (NCT02313259) | CHU de Quebec-Universite Laval | 2012-02-01 |
| MIGS VS SLT Comparison in Glaucoma Patients (NCT02512133) | University of Turin, Italy | 2012-02-01 |
| Astigmatism Post-trabeculectomy (NCT01711190) | Universitaire Ziekenhuizen KU Leuven | 2012-01-01 |
| A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension (NCT01525173) | Allergan | 2012-01-01 |
| Association Between Light Spectrum and Survival After Cataract Surgery (NCT04187157) | University of Pittsburgh | 2012-01-01 |
| Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt (NCT01722604) | Bausch & Lomb Incorporated | 2012-01-01 |
| Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy (NCT01779284) | Aristotle University Of Thessaloniki | 2012-01-01 |
| CEI Van Outreach Screening Study (NCT01510392) | Oregon Health and Science University | 2012-01-01 |
| Prevalence of Glaucoma in the Israeli Arab Population (NCT01546740) | Ziv Hospital | 2012-01-01 |
| AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure (NCT01474135) | Aerie Pharmaceuticals | 2011-12-01 |
| Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America (NCT01518244) | Alcon Research | 2011-12-01 |
| 24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery (NCT01495299) | University of California, San Diego | 2011-12-01 |
| Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect (NCT01491867) | Semmelweis University | 2011-12-01 |
| 24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT) (NCT01495312) | University of California, San Diego | 2011-12-01 |
| Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients (NCT01467388) | University of Zurich | 2011-11-01 |
| GAT-DCT-Discordance Due to Corneal Properties (NCT01474070) | University of Zurich | 2011-11-01 |
| A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01481051) | Mati Therapeutics Inc. | 2011-11-01 |
| Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement (NCT01467453) | University of Zurich | 2011-11-01 |
| Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines (NCT01467440) | University of Zurich | 2011-11-01 |
| A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01481077) | Mati Therapeutics Inc. | 2011-11-01 |
| Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG (NCT02544646) | Medical University of Vienna | 2011-10-13 |
| Drinking Habits of Glaucoma Patients and Age Matched Controls (NCT01503996) | Technische Universität Dresden | 2011-10-01 |
| How Has Glaucoma Affected Your Quality of Life? (NCT01476644) | Wills Eye | 2011-10-01 |
| Are There Changes in the Nerve Fiber Layer (NFL) After Lowering of Eye Pressure? (NCT02600403) | Wills Eye | 2011-10-01 |
| Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP (NCT01639807) | Aurolab | 2011-10-01 |
| Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) (NCT01464424) | Alcon Research | 2011-10-01 |
| Risk Factors for Glaucoma in Musicians (NCT01667861) | Henny Beckers | 2011-10-01 |
| Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada (NCT01415401) | Alcon Research | 2011-09-01 |
| Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery (NCT01440751) | Aeon Astron Europe B.V. | 2011-09-01 |
| Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy (NCT01426464) | Nanduri, Padma, M.D., FACS | 2011-09-01 |
| A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma (NCT01426113) | Allergan | 2011-09-01 |
| The Effects of the Water Drinking Test on Intraocular Pressure (NCT01507584) | University of California, San Diego | 2011-08-01 |
| Eyedrop Instillation Technique (NCT01417689) | Oftalmologia Hospital Sotero del Rio | 2011-08-01 |
| Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma (NCT01383525) | BelkinVision | 2011-07-01 |
| Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma (NCT01401088) | Aurolab | 2011-07-01 |
| Nidek RS3000 Comparative Study (NCT01384487) | Nidek Co. LTD. | 2011-06-01 |
| Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients (NCT02674074) | University Hospital, Basel, Switzerland | 2011-06-01 |
| Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) (NCT01372319) | University Hospital Tuebingen | 2011-06-01 |
| Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01298700) | Allergan | 2011-05-31 |
| Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma. (NCT01314170) | Adapt Produtos Oftalmológicos Ltda. | 2011-05-01 |
| AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure (NCT01484951) | Alcon Research | 2011-05-01 |
| The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma (NCT01351779) | University of Toronto | 2011-05-01 |
| Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients (NCT01262209) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-05-01 |
| Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy (NCT01345448) | Nanduri, Padma, M.D., FACS | 2011-04-01 |
| Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device (NCT01338467) | EyeTechCare | 2011-04-01 |
| Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma. (NCT03166566) | Federal University of Minas Gerais | 2011-03-01 |
| Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy (NCT01263444) | Alcon Research | 2011-03-01 |
| The Detection of Glaucoma Using Pupillography (NCT01462526) | Johns Hopkins University | 2011-03-01 |
| SENSIMED Triggerfish (NCT01319604) | Sensimed AG | 2011-03-01 |
| Ocular Rigidity and Outflow Facility in Glaucomatous and Normal Eyes (NCT01315340) | Larissa University Hospital | 2011-03-01 |
| Clinical Validation Study of RTVue Features (NCT01370850) | Optovue | 2011-03-01 |
| Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow (NCT01308788) | Indiana University | 2011-03-01 |
| AR-12286 in Combination With Latanoprost (NCT01302249) | Aerie Pharmaceuticals | 2011-02-01 |
| Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol (NCT01336569) | Alcon Research | 2011-02-01 |
| Effects of Anti-Glaucoma Medications on the Ocular Surface (NCT01315574) | Massachusetts Eye and Ear Infirmary | 2011-02-01 |
| Glaucoma After Congenital Cataract Surgery (NCT04342052) | Sun Yat-sen University | 2011-01-01 |
| Bimatoprost/Timolol Versus Travoprost/Timolol (NCT01542710) | Kasr El Aini Hospital | 2011-01-01 |
| 24-hour IOP-lowering Effect of 0.01% Bimatoprost (NCT01271686) | University of California, San Diego | 2011-01-01 |
| Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma (NCT01284439) | Mahidol University | 2011-01-01 |
| SENSIMED Triggerfish Safety and Tolerability (NCT01319617) | Sensimed AG | 2011-01-01 |
| Glaucoma After Congenital And Infantile Cataract Surgery (NCT04131114) | Sun Yat-sen University | 2011-01-01 |
| SOLX Gold Shunt for Refractory Glaucoma (NCT01282346) | SOLX, Inc. | 2011-01-01 |
| Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome (NCT01263834) | Prince of Songkla University | 2010-12-01 |
| Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma (NCT01363362) | Technische Universität Dresden | 2010-12-01 |
| Long-Term Non-Interventional Latanoprost Study (NCT01265719) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome (NCT02049333) | Credit Valley EyeCare | 2010-11-01 |
| Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease (NCT01254370) | Santen SAS | 2010-11-01 |
| The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular Rigidity (NCT01247831) | Technische Universität Dresden | 2010-11-01 |
| Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma (NCT01272102) | Carl Zeiss Meditec, Inc. | 2010-11-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension (NCT01216943) | Allergan | 2010-11-01 |
| Confronting Unequal Eye Care in Pennsylvania (NCT01179555) | Wills Eye | 2010-10-01 |
| Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01177098) | Allergan | 2010-10-01 |
| Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (NCT01191008) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension (NCT01229462) | Allergan | 2010-10-01 |
| SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg (NCT01227291) | Sylentis, S.A. | 2010-10-01 |
| Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure (NCT01033422) | Can-Fite BioPharma | 2010-10-01 |
| Safety and Efficacy of Changing to DuoTrav From Prior Therapy (NCT01230736) | Alcon Research | 2010-10-01 |
| Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients (NCT01263535) | Sensimed AG | 2010-09-01 |
| Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma (NCT01471158) | Alcon Research | 2010-09-01 |
| Central Corneal Thickness With SENSIMED Triggerfish (NCT01210963) | Sensimed AG | 2010-09-01 |
| COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy (NCT01228149) | Katrin Lorenz | 2010-08-01 |